In vitro modulation of a resistance artery diameter by the tissue renin- angiotensin system of a large donor artery

Circulation Research

Volumn 80, Issue 2, 1997, Pages 189-195

  Henrion, Daniel ^a   Benessiano, Joëlle ^b   Lévys, Bernard I ^b  

^a HÔPITAL LARIBOISIÈRE   (France)

^b NONE

Author keywords

angiotensin I converting enzyme inhibitor; angiotensin II; captopril; cilazapril; vascular reactivity

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN RECEPTOR ANTAGONIST; BRADYKININ; CAPTOPRIL; CILAZAPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ICATIBANT; LOSARTAN; N(G) NITROARGININE; NITRIC OXIDE SYNTHASE INHIBITOR; PHENYLEPHRINE;

ANIMAL TISSUE; ARTERY DIAMETER; ARTICLE; BLOOD PRESSURE REGULATION; BLOOD VESSEL REACTIVITY; CAROTID ARTERY; HYPERTENSION; ISOLATED ARTERY; MALE; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; VASCULAR RESISTANCE;

EID: 0031019602     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.80.2.189     Document Type: Article

References (42)

1. Waeber W, Nussberger J, Brunner HR. Angiotensin-converting enzyme inhibitors in hypertension. In: Laragh JH, Brenner BM, eds. Hypertension: Pathology, Diagnosis and Management, 2nd ed. New York, NY: Raven Press Publishers; 1995:2861-2875.
2. Campbell DJ. Circulating and tissue angiotensin system. J Clin Invest. 1987;79:1-6.
3. Dzau VJ. Significance of the vascular renin-angiotensin pathway. Hypertension. 1986;8:553-559.
4. Holtz J, Goetz RM. Vascular renin-angiotensin system, endothelial function and atherosclerosis. Basic Res Cardiol. 1994;86:71-86.
5. Samani NJ, Swales JD. Molecular biology of the vascular reninangiotensin system. Blood Vessels. 1991;28:210-216.
6. Okamura T, Miyazaki M, Inagami T, Toda N. Vascular reninangiotensin system in two-kidney one clip hypertensive rats. Hypertension. 1986;8:560-565.
7. Admiraal PJ, Derkx FH, Danser AH, Pieterman H, Schalekamp MA. Metabolism and production of angiotensin I in different vascular beds in subjects with hypertension. Hypertension. 1990;15:44-55.
8. Thurston H, Swales JD, Bing RF, Hurst BC, Marks EF. Vascular renin-like activity and blood pressure maintenance in the rat. Hypertension. 1979;1:643-649.
9. Cassis LA, Lynch KR, Peach MJ. Localization of angiotensinogen messenger RNA in rat aorta. Circ Res. 1988;62:1259-1262.
10. Hilger KF, Mann JFE, Hilgenfeldt U, Ganten D. Vascular production and regulation of angiotensin. Blood Vessels. 1991;28:201-209.
11. Naftilan AJ, Pratt RE, Dzau VJ. Localization and differential regulation of angiotensinogen mRNA expression in the vessel wall. J Clin Invest. 1991;87:1500-1501.
12. von Lutterotti N, Catanzaro DF, Sealey JE, Laragh JH. Renin is not synthesized by cardiac and extrarenal vascular tissues: a review of experimental evidence. Circulation. 1994;89:458-470.
13. Hilgers KF, Hilgenfeldt U, Veelken R, Muley T, Ganten D, Luft FC, Mann JFE. Angiotensinogen is cleaved to angiotensin in isolated rat blood vessels. Hypertension. 1993;21:1030-1034.
14. Arribas S, Sanchez-Ferrer CF, Peiro C, Ponte A, Salaices M, Marin J. Functional vascular renin-angiotensin system in hypertensive transgenic rats for the mouse renin gene Ren-2. Gen Pharmacol. 1994;25:1163-1170.
15. Vicaut E, Hou X. The local renin-angiotensin system in the microcirculation of spontaneously hypertensive rats. Hypertension. 1994; 24:70-76.
16. Caputo L, Tedgui A, Levy BI. Control of the carotid vasomotor tone by local renin-angiotensin system in normotensive and hypertensive rats: role of endothelium and flow. Circ Res. 1995;77:303-309.
17. Christensen KL, Mulvany MJ. Mesenteric arcade arteries contribute substantially to vascular resistance in conscious rats. J Vasc Res. 1993;30:73-79.
18. Halpern W, Osol G, Coy GS. Mechanical behavior of pressurized in vitro prearteriolar vessels determined with a video system. Ann Biomed Eng. 1984;12:463-479.
19. Tedgui A, Lever MJ, Filtration through damaged and undamaged rabbit thoracic aorta. Am J Physiol. 1984;247:H787-H791.
20. Chiu AT, Mc Call DE, Price WA, Wong PC, Carini DJ, Duncia JV, Wexler RR, Yoo SE, Johnson AL, Timmermans PBMWM. In vitro pharmacology of DUP 753. Am J Hypertens. 1991;4:282S-287S.
21. 2 receptor antagonist, Hoe 140, in isolated blood vessels from different species. Br J Pharmacol. 1994;112:683-689.
22. Simon D, Romestand B, Huang H, Badouaille G, Fehrentz JA, Pau B, Marchand J, Corvol P. Direct, simplified and sensitive assay of angiotensin II in plasma extracts performed with a high-affinity monoclonal antibody. Clin Chem. 1992;38:1963-1967.
23. Mombouli J-V, Illiano S, Nagao T, Scott-Burden T, Vanhoutte PM. Potentiation of endothelium-dependent relaxations to bradykinin by angiotensin I converting enzyme inhibitors in canine coronary artery involves both endothelium-derived relaxing and hyperpolarizing factors. Circ Res. 1992;71:137-144.
24. Feletou M, Germain M, Teisseire B. Converting enzyme inhibitors potentiate bradykinin-induced dilation in vitro. Am J Physiol. 1992; 262:H839-H845.
25. Zanziger J, Zheng X, Bassenge E. Endothelium dependent vasomotor responses to endogenous agonists are potentiated following ACE inhibition by a bradykinin dependent mechanism. Cardiovasc Res. 1994;28:209-214.
26. Hecker M, Bara AT, Busse R. Relaxation of isolated coronary arteries by angiotensin-converting enzyme inhibitors: role of endothelium-derived kinins. J Vasc Res. 1993;30:257-262.
27. Pellacani A, Brunner HR, Nussberger J. Plasma kinins increase after angiotensin-converting enzyme inhibition in human subjects. Clin Sci. 1994;87:564-574.
28. Duckles SP. Angiotensin II potentiates responses of the rabbit basilar artery to adrenergic nerve stimulation. Life Sci. 1981;28:40-47.
29. Day MD, Moore AF. Interaction of angiotensin II with noradrenaline and other spasmogens on rabbit isolated aortic strips. Arch Int Pharmacodyn Ther. 1976;219:29-35.
30. Weber MA, Purdy RE, Stupecky GL, Prins BA. Augmentation of sympathomimetic arterial contraction by angiotensin II: a novel mechanism. J Vasc Med Biol. 1989;1:7-15.
31. Benjamin N, Collier JG, Webb DJ. Angiotensin II augments sympathetically induced venoconstriction in man. Clin Sci. 1988;75:337-340.
32. 2+ influx: role of protein kinase C. J Pharmacol Exp Ther. 1992;261:835-842.
33. Henrion D, Laher I, Laporte R, Bevan JA. Further evidence from an elastic artery that angiotensin II amplifies noradrenaline-induced contraction through activation of protein kinase C. Eur J Pharmacol. 1992;224:13-20.
34. Qiu HY, Henrion D, Levy BI. Endogenous angiotensin II potentiates phenylephrine-induced tone in normotensive and hypertensive rats. Hypertension. 1994;24:317-321.
35. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991;43:109-142.
36. Moncada S, Higgs EA. The L-arginine-nitric oxide pathway. N Engl J Med. 1993;329:2002-2012.
37. Buga GM, Gold ME, Fukuto JM, Ignarro LJ. Shear stress-induced release of nitric oxide from endothelial cells grown on beads. Hypertension. 1991;17:187-193.
38. Rubanyi GM, Romero JC, Vanhoutte PM. Flow-induced release of endothelium-derived relaxing factor. Am J Physiol. 1986;250:H1145-H1149.
39. Koller A, Huang A. Impaired nitric oxide-mediated flow-induced dilation in arterioles of spontaneously hypertensive rats. Circ Res. 1994;74:416-421.
40. Bevan JA, Henrion D. Pharmacological implications of the influence of intraluminal flow on smooth muscle tone. Annu Rev Pharmacol Toxicol. 1994;34:173-190.
41. Bardy N, Merval R, Benessiano J, Samuel J-L, Tedgui A. Pressure and angiotensin II synergistically induce aortic fibronectin expression in organ culture model of rabbit aorta: evidence for a pressure-induced tissue renin-angiotensin system. Circ Res. 1996;79:70-78.
42. Koller A, Rodenburg JM, Kaley G. Effects of HOE 140 and ramiprilat on arteriolar tone and dilation to bradykinin in skeletal muscle of rats. Am J Physiol. 1995;268:H1628-H1633.